Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dyadic International (DYAI)
NASDAQ:DYAI
RESEARCH TOOLSreports
Holding DYAI?
Track your performance easily
DYAI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.93 - $2.67
Previous Close$1.75
Volume266.20K
Average Volume (3M)62.01K
Market Cap
$56.37M
Enterprise Value$46.55M
Total Cash (Recent Filing)$9.92M
Total Debt (Recent Filing)$101.57K
Price to Earnings (P/E)―
Beta1.84
Next Earnings
Mar 26, 2025EPS Estimate
-$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding29,589,371
10 Day Avg. Volume282,025
30 Day Avg. Volume62,005
Standard Deviation0.22
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)14.58
Price to Sales (P/S)16.75
Price to Cash Flow (P/CF)-70.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue15.14
Enterprise Value/Gross Profit50.43
Enterprise Value/Ebitda-8.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Dyadic International News
PremiumCompany Announcements
Dyadic International Secures Grant for Antibody Development
PremiumCompany Announcements
Dyadic International Reports Q3 2024 Growth and Strategic Advances
PremiumCompany Announcements
Dyadic International Aligns CFO Incentives with Performance
PremiumPre-Earnings
Is DYAI a Buy, Before Earnings?
PremiumCompany Announcements
Dyadic International Strikes Major Biotech Deal with Proliant
PremiumCompany Announcements
Dyadic International Secures Lucrative Biotech Licensing Deal
Ownership Overview
18.13% Insiders
3.52% Mutual Funds
10.13% Other Institutional Investors
65.48% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DYAI FAQ
What was Dyadic International’s price range in the past 12 months?
Dyadic International lowest stock price was $0.93 and its highest was $2.67 in the past 12 months.
What is Dyadic International’s market cap?
Currently, no data Available
When is Dyadic International’s upcoming earnings report date?
Dyadic International’s upcoming earnings report date is Mar 26, 2025 which is in 94 days.
How were Dyadic International’s earnings last quarter?
Dyadic International released its earnings results on Nov 12, 2024. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.07 by $0.06.
Is Dyadic International overvalued?
According to Wall Street analysts Dyadic International’s price is currently Overvalued.
Does Dyadic International pay dividends?
Dyadic International does not currently pay dividends.
What is Dyadic International’s EPS estimate?
Dyadic International’s EPS estimate is -$0.04.
How many shares outstanding does Dyadic International have?
Dyadic International has 29,589,370 shares outstanding.
What happened to Dyadic International’s price movement after its last earnings report?
Dyadic International reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.07. Following the earnings report the stock price went down -1.754%.
Which hedge fund is a major shareholder of Dyadic International?
Among the largest hedge funds holding Dyadic International’s share is Bandera Partners. It holds Dyadic International’s shares valued at 2M.
---
Dyadic International Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.17%
12-Months-Change
Fundamentals
Return on Equity
-114.42%
Trailing 12-Months
Asset Growth
16.75%
Trailing 12-Months
Company Description
Dyadic International
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
---
DYAI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong positive sentiment, with significant revenue increases and successful collaborations outweighing production cost challenges and market limitations for certain products.Read More>---
DYAI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering DYAI
1 Year
1 Year Success Rate
1/12 ratings generated profit
1 Year Average Return
-30.19%
reiterated a buy rating 6 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 8.33% of your transactions generating a profit, with an average return of -30.19% per trade.
---